Cytarabine, also known as cytosine arabinoside, is a chemotherapy drug commonly used in the treatment of various types of cancer, including leukemia, lymphoma, and certain types of solid tumors. It belongs to a class of medications known as antimetabolites, which work by interfering with the growth and spread of cancer cells in the body.
Cytarabine is typically administered intravenously or through injection into the spinal fluid, depending on the specific type of cancer being treated. It is often used in combination with other chemotherapy drugs to increase its effectiveness and improve outcomes for patients.
As with any chemotherapy medication, cytarabine can cause a range of side effects, including nausea, vomiting, hair loss, and decreased blood cell counts. It is important for patients to discuss these potential side effects with their healthcare provider and to closely monitor their symptoms during treatment.
It is also important for patients to inform their healthcare provider about any other medications or supplements they are taking, as certain drugs may interact with cytarabine and affect its effectiveness or increase the risk of side effects.
Overall, cytarabine is an important and effective medication in the treatment of cancer, and has been shown to significantly improve outcomes for many patients. However, it is crucial for patients to work closely with their healthcare team to monitor their progress and manage any side effects that may arise during treatment.
EN 
ES 
FR 
PT 
ZH